4/A//SEC Filing
Carter Denise P. 4/A
Accession 0001104659-25-059530
CIK 0001671502other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 8:09 PM ET
Size
6.2 KB
Accession
0001104659-25-059530
Insider Transaction Report
Form 4/AAmended
Carter Denise P.
DirectorChief Operating Officer
Transactions
- Award
Share Option (Right to Buy)
2025-05-29+42,857→ 42,857 totalExercise: $9.07Exp: 2035-05-29→ ADS (42,857 underlying)
Footnotes (2)
- [F1]The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares ("ADSs"). Each ADS represents thirty-five ordinary shares of the Issuer. On June 2, 2025, the reporting person filed a Form 4 which inadvertently understated the number of ADSs underlying the option granted to the reporting person on May 29, 2025.
- [F2]The option vests in four annual installments with 20% vesting on each of May 29, 2026, 2027 and 2028 and 40% vesting on May 29, 2029.
Documents
Issuer
Quoin Pharmaceuticals, Ltd.
CIK 0001671502
Entity typeother
Related Parties
1- filerCIK 0001958621
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 8:09 PM ET
- Size
- 6.2 KB